Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma
暂无分享,去创建一个
Tsuyoshi Saito | M. Ishijima | T. Yao | Daisuke Kubota | T. Takagi | A. Yamashita | Takuo Hayashi | Y. Suehara | K. Sasa | Nobuhiko Hasegawa